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Purpose: Improper proliferation of lens epithelial cells is causally related to posterior capsule opacification. In the present
study, we investigated whether small interfering RNA (siRNA)-mediated gene silencing of S-phase kinase-interacting
protein 2 (Skp2) can be employed to inhibit rabbit lens epithelial cell (rLEC) proliferation by increasing the p27kip1 level.
Methods: A plasmid containing Skp2 siRNA was used to decrease the high constitutive level of Skp2 protein in rLECs,
which  can  lead  to  consequent  degradation  of  p27kip1.  Protein  expression  of  Skp2  and  p27kip1  was  detected  by
immunocytochemistry  and  western  blot.  Cell  viability  was  measured  using  the  tetrazolium  reduction  (3-(4,5-
dimethylthiazolyl-2-)-2,5-diphenyltetrazoliumbromide [MTT]) assay. Cell proliferation was assayed by cell counts,
immunocytochemistry, and western blot by using antibodies against proliferating cell nuclear antigen.
Results: Immunocytochemistry and western blot showed a decreased level of Skp2 and increased level of p27kip1 in cells
transfected with pSkp2 siRNA but not in vehicle transfection and uninfected cells. MTT assay showed that cell viability
significantly declined in rLECs transfected with Skp2 siRNA. Skp2 siRNA transfected cells showed significantly less 59-
bromodeoxyuridine- and proliferating cell nuclear antigen-positive staining compared with control cells.
Conclusions: Skp2 siRNA inhibits cell proliferation and decreases cell viability of rLECs in vitro by suppression of
p27kip1 downregulation. Our findings suggest that siRNA-mediated gene silencing of Skp2 can be a novel gene therapy
for posterior capsule opacification induced by LEC abnormal proliferation.
Lens  epithelial  cells  (LECs)  at  the  equatorial  region
continue  proliferating  and  differentiating  throughout  life.
Both withdrawal from the cell cycle and differentiation into
fibers is essential for lens formation and lens transparency
[1]. Improper proliferation of lens epithelial cells after cataract
surgery is causally related to posterior capsule opacification
(PCO) [2,3]. However, the mechanisms underlying lens cell
proliferation are still unclear.
S-phase  kinase-interacting  protein  2  (Skp2)  has  been
identified as an E3 ubiquitin ligase [4] that targets p27kip1 for
ubiquitination [5] and plays an important role in cell-cycle
regulation  [6].  Skp-cullin-F-box  complexes  represent  an
evolutionarily conserved class of E3 enzymes containing four
subunits: Skp1, Cul1, F box proteins, and Roc1/Rbx1 [7].
Skp2 is a rate-limiting component of the machinery that is
specifically  required  for  p27kip1  ubiquitination  and
degradation [5]. Skp2 is frequently overexpressed in tumor
cell  lines,  and  forced  expression  of  Skp2  in  quiescent
fibroblasts induces DNA synthesis [8]. Yoshida et al. [9]
showed  that  expression  of  Skp2  can  be  detected  in  lens
epithelial cells. However, the role of Skp2 in lens epithelial
cell proliferation is still uncertain.
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RNA  interference  (RNAi)  can  easily  and  effectively
inhibit  the  expression  of  a  specific  gene  [10].  The  RNAi
process  is  mediated  through  small,  double-stranded  RNA
molecules called small interfering RNAs (siRNAs), which
specifically trigger the cleavage and subsequent degradation
of  their  target  mRNA  in  a  sequence-dependent  manner.
Therefore, RNAi can prevent synthesis of a protein encoded
by the target mRNA [11]. Recently, RNAi-mediated gene
silencing has been shown to be efficient in mammalian cells,
and  this  has  led  to  the  increasing  feasibility  of  RNAi
technology for the therapy of certain human diseases [12].
IkkapaB kinase subunit beta (IKKβ) targeting siRNA was
reported to inhibit the proliferation of in vitro human Tenon’s
capsule  fibroblast  [13].  Our  recent  study  showed  that
transfection  of  Skp2  siRNA  can  effectively  inhibit  the
proliferation of rabbit tenon’s fibroblast cells after glaucoma
surgery [14].
In this study, we examined the expression of Skp2 in
rabbit LEC (rLEC) and investigated if siRNA-mediated gene
silencing of Skp2 could inhibit p27kip1 downregulation and
repress rLEC proliferation in vitro.
METHODS
All experimental procedures were carried out in accordance
with Harbin Medical University guidelines for animal care
and  the  Guide  for  Care  and  Use  of  Laboratory  Animals
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Source of reagents: Keratin antibody, skp2 antibody, and
streptavidin biotin complex (SABC) kit were purchased from
Boster company (Wuhan, China). P27 kip1 antibody, PCNA
antibody and Enhanced chemiluminescence kit were from
Santa cruz biotechnology Inc (Santa Cruz, CA). Fluorescein-
conjugated anti-sheep IgG was purchased from Zhongshan
biotechnology  (Beijing,  China).  Vectashield  mounting
medium was from Vector laboratories (Burlington, Canada).
Modified  Eagle's  medium  (MEM)  was  from  Gibco
(Burlington, VT). Fetal calf serum, Trizol TM were from
Invitrogen (Carlsbad, CA). Hanks solution was from Hyclone
(Logan,  UT).  Poly-lysine  and  Phosphate  buffer  solution
(PBS) were purchased from Sigma (St. Louis, MO). Culture
plate was from BD Biosciences (San Jose, CA). Hiperfect
transfection  reagent  was  purchased  from  Qiagen  gene
company  (Hilden,  Germany).  Hybond-P  polyvinylidene
difluoride  (PVDF)  membrane  was  from  Amersham
Pharmacia  Biotech  (Piscataway,  NJ).    3-(4,5-
dimethylthiazolyl-2-)-2,5-diphenyltetrazoliumbromide
(MTT)  was  from  Sigma.  MTT  cell  proliferation  kit  was
purchased  from  ATCC  (Manassas,  VA).  Metafectene
Proreagent  was  purchased  from  Biontex,  company
(Martinstried,  Germany).  G418  was  purchased  from  Life
Technologies  company  (Carlsbad,  CA).  Anti-  GAPDH
antibody was purchased from Abcam company (Cambridge,
MA).  Mouse  anti-BrdU-fluorescein  primary  antibody  was
purchased from Roche (Madison,WI).
Equipment used: Fluorescence microscope (IX70) and
optic  microscope  was  purchased  from  Olympus  company
(Tokyo, Japan). CO2 incubator (BB16HF) and ltraclean work
table  (D8C-010)  were  purchased  from  Heal  Force  (Hong
Kong,China). Incubation plate was from Coster corporation
(Cambridge, MA). Cell Counter (Coulter Z1) was purchased
from Coulter company (Hialeah, FL).
Cell culture of rabbit lens epithelial cells: Adult albino
rabbits  weighing  between  2  and  3  kg,  purchased  from
experimental animal center of Harbin Medical University,
were  used  for  experiment.  The  rabbits  used  in  this
investigation were handled in accordance with the tenets of
the Association for Research in Vision and Ophthalmology
(ARVO) Statement for the Use of Animals in Ophthalmic and
Vision Research. Twelve-week-old rabbits weighing 1–1.5 kg
were killed by CO2 inhalation. The entire eye was removed
and dipped in 75% ethanol for 30 s and was then opened from
the  posterior  segment.  The  dissection  procedure  was
performed with sterile instruments under a laminar flow hood.
Lenses were dissected carefully using a posterior approach
and  were  washed  three  times  in  PBS  to  remove  attached
pigments and vitreous. The capsule epithelium was dissected
by fine forceps and placed in a 35-mm2 culture dish where it
adhered to the plastic. Some drops of culture medium were
applied to the epithelium specimens to prevent drying, and the
dishes were placed in a humidified CO2 incubator (5% CO2,
37 °C) for 6 h to allow firm attachment of the capsules.
Another 2 ml of culture medium was then added, and the
capsules were left for 3 or 4 days before the first trypsinization
and subculturing. The medium, which was changed every 2
days, was modified Eagle's medium (MEM) with 10% fetal
bovine serum (FBS), supplemented with 2 mM L-glutamine,
100 U/ml penicillin, and 100 μg/ml streptomycin (all from
Sigma).
rLECs were cultured in a six-well plate with a sterile
coverslip.  All  culture  media  were  as  described  for  the
epithelium specimens. Cells used in subsequent experiments
were generally from passages two to three. All cells were
grown at 37 °C with 5% CO2 ventilation.
Plasmids  and  transfection:  Vector  pSuppressorNeo
generates biologically active siRNAs from the U6promoter.
Synthetic oligonucleotide primers (5′-TCG AGG GAG UGA
CAA AGA CUU UGG AGU ACU GCA AAG UCU UUG
UCA  CUC  CCU  UUU  U-3′)  containing  XhoI  and  XbaI
overhangs  were  annealed  and  then  were  introduced  into
pSuppressor  Neovector.  Oligonucleotide  sequences
correspond  to  a  19-nucleotide  sequence  from  Skp2
(nucleotides  114–133),  which  is  separated  by  an  eight-
nucleotide linker from the reverse complement of the same
19-nucleotide  sequence.  A  transcriptional  termination
(UUUUU) was added to the end of the oligonucleotide. We
used a circular control plasmid, which contains a scrambled
sequence, as a control. rLECs transfected with pSuppressor
containing  Skp2  siRNA,  pSuppressor  only,  and  medium
served as the experimental group, vehicle control group, and
blank  control  group,  respectively.  Transfection  was
performed in 60-mm plates, using 2 µg (1 µg/µl) of vector in
10 µl of Metafectene Proreagent. After 48 h of transfection,
cells were treated with G418 for 2 weeks for positive clone
selection. After G418 treatment, we cloned several stable
transfectant cells. Each clone was screened for expression of
Skp2 by western blot analysis.
Immunocytochemistry: Cells cultured on coverslips were
fixed  with  4%  paraformaldehyde  for  10  min  at  room
temperature, permeabilized, and blocked with 0.1% Triton
X-100 and 5% goat serum for 30 min. Cells were incubated
with rabbit anti-keratin antibody (1:500) at 4 °C overnight,
followed  by  goat-antirabbit  IgG  (1:500)  for  1  h  at  room
temperature. Cells were then incubated with SABC at 37 °C
for 30 min and colored with diaminobenzidine (DAB). This
was followed by dehydration and dimethyl benzene treatment,
and  then  slides  were  mounted.  Controls  were  stained  by
omitting the primary antibody. Skp2 monoclonal antibody
(1:500 dilution), p27kip1 antibody (1:500 dilution), and PCNA
antibody  (1:1,000  dilution)  were  also  used  for
immunofluorescence staining experiments.
Western blot analysis: The protein expression of Skp2,
p27kip1, and PCNA from three different rLEC samples in each
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908treatment was examined by western blot analysis. rLEC cells
(6×105) treated with pSuppressor containing Skp2 siRNA,
pSuppressor only, and medium were prepared in extraction
buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl,
1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS), 1 mM
EDTA, 1 mM 4-(2-Aminoethyl)-benzenesulfonyl (AEBSF),
20 μg/ml aprotinin, and 20 μg/ml leupeptin. Equal amounts of
total protein (10 μg) were separated by 10% sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred  to  a  Hybond-P  polyvinylidene  difluoride
membrane. After blocking with 5% nonfat dry milk in PBS
with 0.1% Tween-20, membranes were probed with anti-Skp2
(1:500),  anti-p27kip1  (1:500),  or  anti-PCNA  mouse
monoclonal antibodies (1:1,000), followed by incubation with
the  appropriate  secondary  antibody.  Visualization  of  the
protein  bands  was  performed  by  the  enhanced
chemiluminescence kit. A parallel western blot was probed
with an anti-GAPDH antibody as a loading control. Band
intensity was quantified using Quantity One 4.4.1 software
(Bio-Rad, Hercules, CA).
3-(4,5-dimethylthiazolyl-2-)-2,5-
diphenyltetrazoliumbromide  assay:  Cell  viability  was
examined by the MTT cell proliferation kit following the
instructions  of  the  manufacturer.  The  assay  is  based  on
measuring  the  reduction  of  yellow  tetrazolium  to  purple
formazan as facilitated by dehydrogenases of metabolically
active cells. The intracellular formazan can be solubilized and
quantified by spectrophotometric means. Quadruple samples
of rLEC were grown on 96-well plates and were infected with
2  µg  (1  µg/µl)  of  either  of  the  two  vectors  in  10  µl  of
Metafectene proreagent or were not infected. After 2, 4, 6, 8,
and 14 days, wells were incubated in a medium containing
yellow tetrazolium for 20 h.
Cell  proliferation  and  bromodeoxyuridine
incorporation: Cells (5.0×103) were plated onto a 24-well
multiwell plate (Falcon; Becton Dickinson, Franklin Lakes,
NJ) and allowed to attach for 24 h. The culture medium was
then replaced with fresh medium. Cells were trypsinized and
counted  with  a  cell  counter  at  0,  2,  4,  and  6  days.  For
bromodeoxyuridine (Brdu) incorporation, cells growing on
coverslips were incubated with 10 µm/l Brdu (Sigma) for 3 h.
After fixing in cold methanol/acetone 1:1 for 10 min, the cells
were sequentially incubated in 1.5 mol/l HCl for 10 min. Cells
were then washed with PBS and incubated with mouse anti-
Figure  1.  Identification  of  rabbit  lens
epithelial  cells  in  vitro.
Immunocytochemistry  demonstrated
expression  of  keratin  protein  in  the
nucleus of cultured cells, indicating that
they were rLECs. The arrow indicates
one rLEC. Scale bar is equal to 80 μm.
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909BrdUrd-fluorescein primary antibody for 1 h. The cells were
washed four times with PBS. The nuclei were simultaneously
stained with 10 µg/ml of 4V, 6-diamidino-2-phenylindole.
Cells  with  different  BrdUrd  incorporation  patterns  were
analyzed  and  counted  with  a  conventional  fluorescence
microscope.
Statistical analysis: The data were analyzed by the two-
tailed Student t test using SPSS 10.0; p<0.05 was considered
significant.
RESULTS
The  identification  of  rabbit  lens  epithelial  cells:  An
immunocytochemistry assay of keratin, a special cell marker
of rLECs, was used in our study to identify rLECs. As shown
in Figure 1, cultured cells expressed keratin protein (brown
staining) in the nucleus, which indicated rLECs.
Downregulation  of  Skp2  protein  by  small  interfering
ribonucleic acid in rabbit lens epithelial cells: After 48 h of
transfection and 2 weeks of treatment with G418, we cloned
several stable transfectant cells. Immunofluorescence staining
demonstrated high constitutive expression of Skp2 protein in
the nucleolus of rLECs transfected with pSuppressor vehicle
(Figure 2B) or without transfection (Figure 2C). Transfection
with Skp2 siRNA dramatically decreased the expression of
Skp2 protein in cells of rLEC (Figure 2A). Each clone was
also screened for expression of Skp2 by western blot analysis.
Skp2 expression can be detected in rLECs of the vehicle
control group and the blank control group (Figure 2D, lanes
2 and 3, respectively). However, there was little expression of
Skp2  in  the  experimental  group,  which  indicated  that
transfection with Skp2 siRNA can inhibit expression of Skp2
in rLECs in vitro (Figure 2D, lane 1).
Upregulation  of  p27kip1  protein  by  Skp2  small  interfering
ribonucleic  acid  in  rabbit  lens  epithelial  cells:  Skp2  is
required for the ubiquitination and consequent degradation of
p27kip1 [2]. Immunofluorescence staining demonstrated little
expression  of  p27  protein  in  the  rLECs  transfected  with
pSuppressor  vehicle  (Figure  3A)  or  without  transfection
(Figure 3B). Transfection with Skp2 siRNA increased the
expression of p27kip1 protein in rLECs (Figure 3C) in vitro.
Western blot analysis in our study demonstrated that p27kip1
expression  of  rLECs  in  the  experimental  group  increased
(Figure  3D,  lane  3)  when  expression  of  Skp2  decreased
(Figure 2). Upregulation of p27kip1 made it possible for us to
investigate the effect of p27kip1 inhibition on the proliferation
of rLECs.
Skp2 small interfering ribonucleic acid decreased the rabbit
lens epithelial cells viability and proliferation in vitro:
3-(4,5-dimethylthiazolyl-2-)-2,5-
diphenyltetrazoliumbromide (MTT)—As shown in Figure
4, cell viability did not show any significant differences after
vehicle transfection compared with the blank control group,
indicating that the plasmid did not influence cell metabolism.
Figure 2. Downregulation of S phase-
kinase-interacting protein 2 protein by
small  interfering  ribonucleic  acid  in
rabbit  len  epithelial  cells  in  vitro.
Immunocytochemistry  staining  (one
representative  of  three  experiments)
indicated  high  constitutive  levels  of
Skp2 protein (indicated by arrow) in the
nucleolus  of  rLECs  transfected  with
pSuppressor  vehicle  (B)  or  without
transfection (C). Transfection with Skp2
siRNA  dramatically  decreased  the
expression  of  Skp2  protein  in  rLECs
(A). Scale bar is equal to 40 μm. After
48  h  of  transfection  and  2  weeks  of
treatment  with  G418,  several  stable
transfectant cells were cloned. Western
blot analysis (one representative of three
experiments)  showed  that  high
constitutive  Skp2  expression  can  be
detected in rLECs of the vehicle control
group  and  blank  control  group  (D).
However, little expression of Skp2 was
detected  in  the  experimental  group,
indicating  transfection  with  Skp2
siRNA can inhibit expression of Skp2 in
rLECs in vitro (D). GAPDH served as
loading control.
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910However, cell viability in Skp2 siRNA transfected rLECs
(experimental group) significantly decreased at 6 and 10 days
after transfection when compared with the vehicle control and
blank control.
Incorporation  of  bromodeoxyuridine—High-level
staining of Brdu was detected in the rLECs of the vehicle
control  (Figure  5A)  and  blank  control  (Figure  5B)  but
dramatically  decreased  in  Skp2  siRNA  transfectant  cells
(Figure  5C).  Statistical  analysis  (Figure  5D)  after  cell
counting  showed  that  BrdU-positive  cells  in  rLECs
transfected  with  Skp2  siRNA  significantly  decreased
compared with control cells (p<0.01 versus vehicle and blank
controls).
PCNA protein expression in rLECs after transfection with
Skp2 siRNA: PCNA is a marker that indicates the proliferation
potential of cells. Immunofluorescence staining demonstrated
obvious expression of PCNA protein in the rLECs transfected
with  the  pSuppressor  vehicle  (Figure  6A)  or  without
transfection  (Figure  6B)  in  vitro.  Transfection  with  Skp2
siRNA decreased the expression of PCNA protein in rLECs
(Figure 6C) in vitro. Western blot further confirmed that the
expression  of  PCNA  dramatically  decreased  after  rLEC
Figure  3.  S  phase-kinase-interacting
protein 2 protein by small interfering
ribonucleic  acid  induced  p27  kinase
inhibition  protein  1in  rabbit  lens
epithelial  cells  in  vitro.
Immunofluorescence staining indicated
the expression of p27kip1 dramatically
increased  in  rLECs  transfected  with
Skp2 siRNA (C) when compared with
rLECs  transfected  with  pSuppressor
vehicle (A) or without transfection (B).
The scale bar is equal to 40 μm. Western
blot  (one  representative  of  three
experiments)  showed  that  the
expression  of  p27kip1  dramatically
increased  in  rLECs  transfected  with
Skp2 siRNA (D) when compared with
rLECs  transfected  with  pSuppressor
vehicle (D) or without transfection (D).
GAPDH served as the loading control.
Figure 4. Cell viability assay by 3-(4,5-
dimethylthiazolyl-2-)-2,5-
diphenyltetrazoliumbromide  (MTT).
After transfection with Skp2 siRNA, cell
viability was significantly decreased in
cultured  rLECs  at  days  6  and  10
compared with the vehicle control and
blank  control.  The  asterisk  indicates
p<0.05  versus  the  vehicle  and  blank
controls,  while  the  double  asterisk
indicates p<0.01 versus the vehicle and
blank controls (n=32).
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911transfection  with  Skp2  siRNA  (Figure  6D,  lane  3)  when
compared with rLEC transfection with pSuppressor vehicle
(Figure 6D, lane 1) or without transfection (Figure 6D, lane
2).
DISCUSSION
Cataract surgery can induce a wound-healing response in the
lens that leads to PCO. PCO incidence is approximately 50%
in adults and 100% in children after cataract surgery [15] and
is the most common postoperative complication of cataract
surgery that causes visual loss [16]. PCO arises from residual
LECs at the equator and under the anterior lens capsule after
cataract surgery. These cells proliferate and migrate onto the
posterior capsule underlying the intraocular lens and into the
light  path.  Many  of  these  cells  undergo  epithelial-to-
mesenchymal transition (EMT), resulting in the formation of
fibroblasts  and  spindle-like  myofibroblasts,  which  lead  to
capsular opacity [16]. Clinically, there are two morphological
types of PCO: fibrosis type and pearl type. The fibrosis-type
PCO is caused by the proliferation and migration of LECs,
which undergo EMT [15-18]. In the pearl-type PCO, LECs
located at the equatorial lens region can cause regeneration of
crystallin-expressing  lenticular  fibers  and  form  Elschnig
pearls and a Soemmering ring.
The  histological  features  of  PCO  are  now  well
established, but to date the molecular mechanisms influencing
leftover  LEC  behavior  after  cataract  surgery  are  not
completely clear. LECs left behind in the capsular bag after
any  type  of  extracapsular  cataract  surgery  are  mainly
responsible for PCO development [1], which involves LEC
abnormal proliferation, migration, EMT, collagen deposition,
and lens fiber regeneration [19-21].
Studies show that levels of several cytokines and growth
factors  increase  in  the  aqueous  humor  and  influence  the
behavior of the remaining LECs after cataract surgery. These
factors include transforming growth factor [22-24], fibroblast
growth factor 2, hepatocyte growth factor, and interleukins 1
and 6 [25,26].
Cellular proliferation is regulated primarily by cell-cycle
regulation.  Cell-cycle  progression  is  regulated  by  a
combination  of  positive  and  negative  regulators.  Cyclin-
dependent  kinase  (CDKs)  inhibitors  (CKI)  negatively
regulate progression of the cell cycle by inhibiting the activity
of  cyclin-CDK  complexes.  p27kip1,  a  member  of  the  CKI
family, plays a pivotal role in the control of cell proliferation
[27-29]. The level of p27kip1 is high during the G0 phase but
decreases rapidly upon re-entry of the cells into the G1 phase.
Rapid removal of p27kip1 at the G0/G1 transition is required for
effective progression of the cell cycle to S phase [30-32]. In
previous  studies,  Yoshida  et  al.  [33]  suggested  that  the
disappearance of p27kip1 was correlated with cell proliferation
in the corneal epithelium after injury. According to our study,
a low level of p27kip1 expression was correlated with high
proliferative  and  migratory  capacity,  whereas  nuclear
accumulation of the CKI was associated with a quiescent and
static phenotype.
Figure  5.  S  phase-kinase-interacting
protein 2 protein by small interfering
ribonucleic  acid  inhibited  cell
proliferation of rabbit len epithelial cells
in  vitro  (3-(4,5-
dimethylthiazolyl-2-)-2,5-
diphenyltetrazoliumbromide). For Brdu
incorporation,  cells  growing  on
coverslips  were  incubated  with  Brdu.
Incorporated  Brdu  was  detected  with
antibodies as described in the Materials
and Methods. High levels of BrdU with
dense brown staining can be detected in
rLEC of vehicle control (A) and blank
control  (B),  but  decreased  in  Skp2
siRNA transfectant cells (C). Statistical
analysis (D) after cell counting showed
that Brdu positive cells decreased after
rLEC  transfection  with  Skp2  siRNA
compared  with  control  cells.  p<0.01
versus vehicle and blank control (n=32).
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912The  level  of  p27kip1  is  regulated  by  Skp2.  Skp2  is
specifically required for p27kip1 ubiquitination and is a rate-
limiting  component  of  the  machinery  that  degrades
phosphorylated p27kip1 [22]. Skp2 is constitutively expressed
in normal skin tissue and scar tissue. High expression of Skp2
and decreased expression of p27kip1 are observed in fibroblast
from pathological scar tissue [30], which indicates a negative
correlation  between  expression  of  Skp2  and  p27kip1  in
fibroblasts from pathological scar tissue. However, there have
been  no  previous  studies  on  the  role  of  Skp2  in  LEC
proliferation. Our study demonstrated that Skp2 was highly
expressed and p27kip1 displayed little expression in rLECs.
Furthermore, we showed that inhibition of Skp2 expression
by siRNA enhanced the p27kip1 protein level and prevented
rLEC proliferation.
At  present,  the  only  effective  treatment  of  PCO  is
neodymium-doped  yttrium  aluminium  garnet  (Nd:YAG)
laser capsulotomy, which involves clearing the visual axis by
creating a central opening in the opacified posterior capsule.
Although  this  procedure  is  easy  and  rapid,  there  are
complications, including retinal detachment, damage to the
intraocular lens (IOL), cystoid macular edema, an increase in
intraocular pressure, iris hemorrhage, corneal edema, IOL
subluxation, and exacerbation of localized endophthalmitis.
Changes induced by Nd:YAG capsulotomy have been shown
to be affected by IOL material and design. In addition, this
treatment represents a considerable cost burden to national
health care systems, and such laser treatment is not readily
available  in  developing  countries.  Therefore,  a  better
understanding of the pathogenic mechanism of PCO is highly
desirable as a basis for improving the outcome of cataract
surgery and eradicating PCO [34-36].
Approaches to inhibiting LEC proliferation after cataract
surgery  by  gene  transfer  have  been  reported  by  different
research groups. Malecaze et al. [37] and Counderec et al.
[38] delivered adenoviral vector-mediated transfer systems,
including herpes simplex virus-thymidine kinase/ganciclovir
(HSV-tk/GCV) into rabbit LECs in vitro, which can inhibit
the proliferation of rLECs. Malecaze et al. [39] demonstrated
that adenoviral-mediated Bax or procaspase-3 overexpression
is capable of inducing therapeutic programmed cell death in
vitro and in vivo in residual lens cells and preventing PCO in
a rabbit model. Kampmeier et al. [40] showed that transfection
of  antisense  cyclin  G1  retroviral  vectors  can  inhibit
proliferation of LECs. In this study we showed that siRNA
targeting Skp2 prevented rLEC proliferation in vitro. Thus,
the  method  might  be  used  to  prevent  PCO  after  cataract
surgery.
Finally, in view of the growing interest in Skp2 and p27kip1
as  a  target  for  drug  development  in  inhibiting  LEC
proliferation following cataract surgery, it is our hope that the
data presented here will help to decrease the PCO incidence
from cataract surgery.
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compared with rLEC transfection with
the  pSuppressor  vehicle  or  without
transfection.  GAPDH  served  as  the
loading control.
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